Bristol-Myers Squibb
BMY
#177
Rank
C$184.46 B
Marketcap
C$90.30
Share price
0.89%
Change (1 day)
42.96%
Change (1 year)

Bristol-Myers Squibb (BMY) - P/B ratio

P/B ratio as of August 2026 : 6.58

According to Bristol-Myers Squibb's latest financial reports the company has a price-to-book ratio of 2.72682.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Bristol-Myers Squibb - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-315.88-17.62%
2024-12-317.14101.6%
2023-12-313.54-27.97%
2022-12-314.9227.9%
2021-12-313.843.88%
2020-12-313.7033.76%
2019-12-312.77-53.7%
2018-12-315.98-29.42%
2017-12-318.4741.7%
2016-12-315.97-24.58%
2015-12-317.9221.64%
2014-12-316.5113.76%
2013-12-315.7246.97%
2012-12-313.903.5%
2011-12-313.7630.82%
2010-12-312.88-1.43%
2009-12-312.92-22.59%
2008-12-313.77-23.94%
2007-12-314.96-4.1%
2006-12-315.1728.81%
2005-12-314.01-17.94%
2004-12-314.89-13.76%
2003-12-315.679.77%
2002-12-315.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.70 17.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.63 16.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.69-74.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-65.8-1,099.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
33.9 415.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
24.1 266.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.23-81.30%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
1.65-74.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6.91 5.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.28-19.67%๐Ÿ‡ฌ๐Ÿ‡ง UK